Related Experiment Video

Updated: Jul 11, 2025

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.0K

Uniting innate and adaptive immunity in glioblastoma; an α-CTLA-4 quest

Nicolas Camviel1, Leila Akkari1

  • 1Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

Trends in Immunology
|November 10, 2023
PubMed

Insights

Glioblastoma immunotherapy shows promise with an alpha-CTLA-4 antibody (Ab) in mice. This treatment activates CD4+ Th1 T cells and microglia for a strong antitumor response against mesenchymal-like glioblastoma.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cancer research

Background:

  • Immunotherapy has shown limited success in treating glioblastoma.
  • Glioblastoma remains a challenging brain tumor with poor prognoses.

Purpose of the Study:

  • To investigate the therapeutic potential of an alpha-CTLA-4 antibody (Ab) in glioblastoma.
  • To elucidate the mechanisms underlying the efficacy of alpha-CTLA-4 Ab in a preclinical glioblastoma model.

Main Methods:

  • Utilized a murine model of mesenchymal-like glioblastoma.
  • Administered an alpha-CTLA-4 antibody (Ab) for therapeutic intervention.
  • Analyzed the immune cell populations and their interactions within the tumor microenvironment.

Main Results:

  • The alpha-CTLA-4 antibody (Ab) demonstrated significant therapeutic efficacy in reducing tumor burden.
  • Efficacy was dependent on the synergistic action of CD4+ Th1 T cells and microglia.
  • This immune cell cooperation resulted in a potent antitumor response.

Conclusions:

  • Alpha-CTLA-4 antibody (Ab) therapy holds therapeutic potential for glioblastoma, particularly the mesenchymal subtype.
  • The combination of CD4+ Th1 T cells and microglia is crucial for alpha-CTLA-4 Ab-mediated antitumor activity.
  • Further research into this immunotherapy approach could lead to novel glioblastoma treatments.

More Related Videos

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

15.9K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
533